Biropepimut-S Uses, Dosage, Side Effects and more
Biropepimut-S is under investigation in clinical trial NCT02873819 (Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity).
| Attribute | Details |
|---|---|
| Trade Name | Biropepimut-S |
| Generic | Biropepimut-S |
| Biropepimut-S Other Names | Biropepimut-S |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
